Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Sabra Health Care REIT, Inc.SBRA · Entity 886 | Executive VP, CFO & Treasurer | August 31, 2026 | September 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Sabra Health Care REIT, Inc.
Report date August 31, 2026 · Filed September 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 469,879 |
Reported balance
After 2026-08-31 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-08-31 · Grant · Acquired 4,158 · Balance 469,879 F1: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2: Includes 286,773 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. |
| Common StockSEC Table I · non-derivative | IndirectBy Reporting Person's IRA | 784 |
Reported balance
Holding disclosure · report date 2026-08-31 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 784 |
| Common StockSEC Table I · non-derivative | IndirectBy Reporting Person's Spouse's IRA | 207 |
Reported balance
Holding disclosure · report date 2026-08-31 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 207 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.
F2: Includes 286,773 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 31, 2026 Filed Sep 2, 2026 21:31 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 4,158 | $0.00 | $0.00 |
DisclosureSEC source: 0001838630-26-000014 · wk-form4_1788384698.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 469,879 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 286,773 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 19:13 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 4,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001838630-26-000010 · wk-form4_1780427578.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 465,721 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 282,615 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 19:23 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 4,005 | $0.00 | $0.00 |
DisclosureSEC source: 0001838630-26-000008 · wk-form4_1772565789.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 461,521 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 278,415 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| February 10, 2026 Filed Feb 13, 2026 01:28 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 22,848 | $0.00 | $0.00 |
DisclosureSEC source: 0001838630-26-000006 · wk-form4_1770946090.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 457,516 F1 · shares: Represents the vesting of stock units granted under the Issuer's 2009 Performance Incentive Plan subject to a funds from operations-based stock unit ("FFO units") award granted on December 27, 2022, including 4,803 shares with respect to dividend equivalent payments calculated based on the market value of the Issuer's Common Stock on the applicable dividend date. The Compensation Committee determined on February 10, 2026 that the number of FFO units earned was 90.8% of the target. Upon this determination, the FFO units vested immediately. Each FFO unit represented a contingent right to receive one share of the Issuer's Common Stock, based on the Issuer's achievement of a funds from operations target for a performance period beginning January 1, 2025 and ending December 31, 2025. The vested units will be paid on a one-for-one basis in shares of the Issuer's Common Stock on January 4, 2027, subject to earlier payment in the event of death, disability or change of control. F2 · balance_after: Includes 274,410 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| January 08, 2026 Filed Jan 13, 2026 00:08 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | Tax withholdingCommon Stock | 46,132 | $19.61 | $904,648.52 |
DisclosureSEC source: 0001838630-26-000004 · wk-form4_1768262895.xml · nonDerivative · entry 2 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 434,668 F2 · shares: Represents shares withheld by the Issuer in accordance with Rule 16b-3 to satisfy tax withholding obligations in connection with the payout of previously vested restricted stock units previously granted to the reporting person. F3 · balance_after: Includes 251,562 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| January 08, 2026 Filed Jan 13, 2026 00:08 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 85,690 | $0.00 | $0.00 |
DisclosureSEC source: 0001838630-26-000004 · wk-form4_1768262895.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 480,800 F1 · shares: Represents the vesting of stock units granted under the Issuer's 2009 Performance Incentive Plan subject to a relative total stockholder return-based stock unit ("TSR units") award granted on December 27, 2022, including 18,014 shares with respect to dividend equivalent payments calculated based on the market value of the Issuer's Common Stock on the applicable dividend date. The Compensation Committee determined on January 8, 2026 that the number of TSR units earned was 200% of the target, based on the percentile ranking of the Issuer's total stockholder return among the total stockholder returns for the stocks comprising a group of pre-selected peer companies over the three-year performance period. Upon this determination, the TSR units vested immediately. The vested units will be paid on a one-for-one basis in shares of the Issuer's Common Stock on or about January 2, 2027, subject to earlier payment in the event of death, disability or change of control. Read SEC document |
| December 31, 2025 Filed Jan 6, 2026 00:58 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 39,831 | $0.00 | $0.00 |
DisclosureSEC source: 0001838630-26-000002 · wk-form4_1767661078.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 395,110 F1 · shares: Grant of stock units under the Issuer's 2009 Performance Incentive Plan. The units vest at the rate of 25% on each of December 31, 2026, December 31, 2027, December 31, 2028 and December 31, 2029. The vested units will be paid on a one-for-one basis in shares of the Issuer's Common Stock in the 2030 calendar year, subject to earlier payment in the event of separation from service, death, disability or change of control. F2 · balance_after: Includes 268,068 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| November 28, 2025 Filed Dec 2, 2025 20:22 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 3,457 | $0.00 | $0.00 |
DisclosureSEC source: 0001838630-25-000008 · wk-form4_1764706945.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 355,279 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 228,237 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| August 29, 2025 Filed Sep 3, 2025 18:09 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 3,473 | $0.00 | $0.00 |
DisclosureSEC source: 0001838630-25-000006 · wk-form4_1756922967.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 351,822 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 224,780 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:20 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 3,736 | $0.00 | $0.00 |
DisclosureSEC source: 0001976617-25-000060 · wk-form4_1748982026.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 348,349 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 221,307 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 19:44 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 3,858 | $0.00 | $0.00 |
DisclosureSEC source: 0001976617-25-000031 · wk-form4_1741117480.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 344,613 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 217,571 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 20:56 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 63,782 | $0.00 | $0.00 |
DisclosureSEC source: 0001976617-25-000014 · wk-form4_1737147375.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 340,755 F1 · shares: Represents the vesting of stock units granted under the Issuer's 2009 Performance Incentive Plan subject to a relative total stockholder return-based stock unit ("TSR units") award granted on December 28, 2021, including 14,420 shares with respect to dividend equivalent payments calculated based on the market value of the Issuer's Common Stock on the applicable dividend date. The Compensation Committee determined on January 15, 2025 that the number of TSR units earned was 200% of the target, based on the percentile ranking of the Issuer's total stockholder return among the total stockholder returns for the stocks comprising a group of pre-selected peer companies over the three-year performance period. Upon this determination, the TSR units vested immediately. The vested units will be paid on a one-for-one basis in shares of the Issuer's Common Stock on or about January 2, 2026, subject to earlier payment in the event of death, disability or change of control. F2 · balance_after: Includes 213,713 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 20:18 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | Tax withholdingCommon Stock | 15,783 | $17.18 | $271,151.94 |
DisclosureSEC source: 0001976617-25-000006 · wk-form4_1736540282.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 276,973 F1 · shares: Represents shares withheld by the Issuer in accordance with Rule 16b-3 to satisfy tax withholding obligations in connection with the payout of previously vested restricted stock units previously granted to the reporting person. F2 · balance_after: Includes 149,931 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| December 27, 2024 Filed Dec 31, 2024 19:13 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 37,477 | $0.00 | $0.00 |
DisclosureSEC source: 0001976617-24-000091 · wk-form4_1735672422.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 292,756 F1 · shares: Grant of stock units under the Issuer's 2009 Performance Incentive Plan. The units vest at the rate of 25% on each of December 31, 2025, December 31, 2026, December 31, 2027 and December 31, 2028. The vested units will be paid on a one-for-one basis in shares of the Issuer's Common Stock in the 2029 calendar year, subject to earlier payment in the event of separation from service, death, disability or change of control. F2 · balance_after: Includes 191,547 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 22:32 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 2,429 | $0.00 | $0.00 |
DisclosureSEC source: 0001862128-24-000039 · wk-form4_1733265144.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 255,279 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 154,070 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| August 30, 2024 Filed Sep 5, 2024 00:57 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 2,624 | $0.00 | $0.00 |
DisclosureSEC source: 0001976617-24-000074 · wk-form4_1725496861.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 252,850 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 151,641 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 22:40 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 3,004 | $0.00 | $0.00 |
DisclosureSEC source: 0001976617-24-000038 · wk-form4_1717540794.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,226 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 149,017 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 18:35 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 3,089 | $0.00 | $0.00 |
DisclosureSEC source: 0001862128-24-000013 · wk-form4_1709577323.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 247,222 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 146,013 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:25 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 23,209 | $0.00 | $0.00 |
DisclosureSEC source: 0001976617-24-000023 · wk-form4_1706909124.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 244,133 F1 · shares: Represents the vesting of stock units granted under the Issuer's 2009 Performance Incentive Plan subject to a relative total stockholder return-based stock unit ("TSR units") award granted on December 24, 2020, including 5,260 shares with respect to dividend equivalent payments calculated based on the market value of the Issuer's Common Stock on the applicable dividend date. The Compensation Committee determined on January 31, 2024 that the number of TSR units earned was 148.84% of the target, based on the percentile ranking of the Issuer's total stockholder return among the total stockholder returns for the stocks comprising a group of pre-selected peer companies over the three-year performance period. Upon this determination, the TSR units vested immediately. The vested units will be paid on a one-for-one basis in shares of the Issuer's Common Stock on or about January 2, 2025, subject to earlier payment in the event of death, disability or change of control. F2 · balance_after: Includes 142,924 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 21:05 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | Tax withholdingCommon Stock | 468 | $13.64 | $6,383.52 |
DisclosureSEC source: 0001976617-24-000015 · wk-form4_1704834306.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 220,924 F1 · shares: Represents shares withheld by the Issuer in accordance with Rule 16b-3 to satisfy tax withholding obligations in connection with the payout of previously vested restricted stock units previously granted to the reporting person. F2 · balance_after: Includes 119,715 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| December 28, 2023 Filed Jan 2, 2024 21:01 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 36,468 | $0.00 | $0.00 |
DisclosureSEC source: 0001976617-24-000005 · wk-form4_1704229291.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 221,392 F1 · shares: Grant of stock units under the Issuer's 2009 Performance Incentive Plan. The units vest at the rate of 25% on each of December 31, 2024, December 31, 2025, December 31, 2026 and December 31, 2027. The vested units will be paid on a one-for-one basis in shares of the Issuer's Common Stock in the 2028 calendar year, subject to earlier payment in the event of separation from service, death, disability or change of control. F2 · balance_after: Includes 121,186 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 19:35 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 1,706 | $0.00 | $0.00 |
DisclosureSEC source: 0001976617-23-000048 · wk-form4_1701718496.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 184,924 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 84,718 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 22:31 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | PurchaseCommon Stock | 1,947 | $12.63 | $24,590.61 |
DisclosureSEC source: 0001862128-23-000036 · wk-form4_1693953050.xml · nonDerivative · entry 2 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,218 F2 · balance_after: Includes 83,012 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| August 31, 2023 Filed Sep 5, 2023 22:31 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 1,942 | $0.00 | $0.00 |
DisclosureSEC source: 0001862128-23-000036 · wk-form4_1693953050.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 181,271 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 21:24 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 2,103 | $0.00 | $0.00 |
DisclosureSEC source: 0001976617-23-000013 · wf-form4_168574103528078.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 179,329 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 81,070 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 00:05 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | Tax withholdingCommon Stock | 5,151 | $11.80 | $60,781.80 |
DisclosureSEC source: 0001862128-23-000024 · wf-form4_167780191846166.xml · nonDerivative · entry 3 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,226 F3 · shares: Represents shares withheld by the Issuer in accordance with Rule 16b-3 to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. F4 · balance_after: Includes 78,967 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 00:05 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 14,894 | $0.00 | $0.00 |
DisclosureSEC source: 0001862128-23-000024 · wf-form4_167780191846166.xml · nonDerivative · entry 2 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,377 F2 · shares: Represents shares of the Issuer's Common Stock issued under the Issuer's 2009 Performance Incentive Plan subject to an annual bonus performance stock unit ("PSU") award granted on August 10, 2022, including 1,357 shares with respect to dividend equivalent payments calculated based on the market value of the Issuer's Common Stock on the applicable dividend date. The Compensation Committee determined on March 1, 2023 that the number of PSUs earned was 115.2% of the target. Upon this determination, the PSUs vested and were paid out immediately. Each PSU represented a contingent right to receive one share of the Issuer's Common Stock, based on the Issuer's achievement of an adjusted normalized funds from operations per share target for a performance period beginning January 1, 2022 and ending December 31, 2022. Read SEC document |
| February 28, 2023 Filed Mar 3, 2023 00:05 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 1,939 | $0.00 | $0.00 |
DisclosureSEC source: 0001862128-23-000024 · wf-form4_167780191846166.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,483 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. Read SEC document |
| January 28, 2023 Filed Feb 1, 2023 00:25 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | Tax withholdingCommon Stock | 1,532 | $13.46 | $20,620.72 |
DisclosureSEC source: 0001862128-23-000011 · wf-form4_167521109228697.xml · nonDerivative · entry 2 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,544 F2 · shares: Represents shares withheld by the Issuer in accordance with Rule 16b-3 to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the reporting person. F3 · balance_after: Includes 77,028 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| January 28, 2023 Filed Feb 1, 2023 00:25 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 4,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001862128-23-000011 · wf-form4_167521109228697.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,076 F1 · shares: Represents the vesting of stock units granted under the Issuer's 2009 Performance Incentive Plan subject to a relative total stockholder return-based stock unit ("TSR units") award granted on December 24, 2019, including 963 shares with respect to dividend equivalent payments calculated based on the market value of the Issuer's Common Stock on the applicable dividend date. The Compensation Committee determined on January 28, 2023 that the number of TSR units earned was 71.61% of the target, based on the percentile ranking of the Issuer's total stockholder return among the total stockholder returns for the stocks comprising a group of pre-selected peer companies over the three-year performance period. Upon this determination, the TSR units vested and were settled immediately. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 23:37 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | Tax withholdingCommon Stock | 1,008 | $13.10 | $13,204.80 |
DisclosureSEC source: 0001862128-23-000005 · wf-form4_167304824195997.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,639 F1 · shares: Represents shares withheld by the Issuer in accordance with Rule 16b-3 to satisfy tax withholding obligations in connection with the payout of previously vested restricted stock units previously granted to the reporting person. F2 · balance_after: Includes 77,028 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| December 27, 2022 Filed Dec 30, 2022 01:15 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 34,777 | $0.00 | $0.00 |
DisclosureSEC source: 0001862128-22-000112 · wf-form4_167236294264250.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,647 F1 · shares: Grant of stock units under the Issuer's 2009 Performance Incentive Plan (the "Plan"). The units vest at the rate of 25% on each of December 31, 2023, December 31, 2024, December 31, 2025 and December 31, 2026. The vested units will be paid on a one-for-one basis in shares of the Issuer's Common Stock in the 2027 calendar year, subject to earlier payment in the event of separation from service, death, disability or change of control. F2 · balance_after: Includes 79,498 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 22:10 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 1,016 | $0.00 | $0.00 |
DisclosureSEC source: 0001862128-22-000099 · wf-form4_167001903438021.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,870 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 44,721 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| August 31, 2022 Filed Sep 2, 2022 20:02 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 859 | $0.00 | $0.00 |
DisclosureSEC source: 0001862128-22-000077 · wf-form4_166214895483600.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,854 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 43,705 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 20:13 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 897 | $0.00 | $0.00 |
DisclosureSEC source: 0001862128-22-000043 · wf-form4_165420080557562.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,995 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 42,846 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 01:25 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 916 | $0.00 | $0.00 |
DisclosureSEC source: 0001862128-22-000020 · wf-form4_164618430175916.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,098 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 41,949 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| December 31, 2021 Filed Jan 6, 2022 23:45 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | Tax withholdingCommon Stock | 1,325 | $13.54 | $17,940.50 |
DisclosureSEC source: 0001862128-22-000004 · wf-form4_164151269387275.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP, CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,182 F1 · shares: Represents shares withheld by the Issuer in accordance with Rule 16b-3 to satisfy tax withholding obligations in connection with the payout of previously vested restricted stock units previously granted to the reporting person. F2 · balance_after: Includes 41,033 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| December 28, 2021 Filed Dec 30, 2021 21:13 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 24,696 | $0.00 | $0.00 |
DisclosureSEC source: 0001862128-21-000109 · wf-form4_164089878167086.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,507 F1 · shares: Grant of stock units under the Issuer's 2009 Performance Incentive Plan (the "Plan"). The units vest at the rate of 25% on each of December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. The vested units will be paid on a one-for-one basis in shares of the Issuer's Common Stock in the 2026 calendar year, subject to earlier payment in the event of separation from service, death, disability or change of control. F2 · balance_after: Includes 44,264 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 21:42 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 444 | $0.00 | $0.00 |
DisclosureSEC source: 0001862128-21-000093 · wf-form4_163848131478741.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,811 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 19,568 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 20:19 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 353 | $0.00 | $0.00 |
DisclosureSEC source: 0001862128-21-000067 · wf-form4_163061391564766.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,367 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 19,124 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 18:14 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 315 | $0.00 | $0.00 |
DisclosureSEC source: 0001862128-21-000020 · wf-form4_162265764506573.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,014 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 18,771 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| February 26, 2021 Filed Mar 3, 2021 00:55 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 316 | $0.00 | $0.00 |
DisclosureSEC source: 0001510192-21-000038 · wf-form4_161473291975367.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,409 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 18,456 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| January 13, 2021 Filed Jan 16, 2021 01:28 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | Tax withholdingCommon Stock | 2,246 | $17.20 | $38,631.20 |
DisclosureSEC source: 0001510192-21-000020 · wf-form4_161076051718940.xml · nonDerivative · entry 2 Costa Michael Lourenco · CIK 0001838630 · Executive VP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,093 F2 · shares: Represents shares withheld by the Issuer in accordance with Rule 16b-3 to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the reporting person. F3 · balance_after: Includes 18,140 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| January 13, 2021 Filed Jan 16, 2021 01:28 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 5,988 | $0.00 | $0.00 |
DisclosureSEC source: 0001510192-21-000020 · wf-form4_161076051718940.xml · nonDerivative · entry 1 Costa Michael Lourenco · CIK 0001838630 · Executive VP & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,339 F1 · shares: Represents the vesting of stock units granted under the Issuer's 2009 Performance Incentive Plan subject to a relative total stockholder return-based stock unit ("TSR units") award granted on December 27, 2017, including 1,374 shares with respect to dividend equivalent payments calculated based on the market value of the Issuer's Common Stock on the applicable dividend date. The Compensation Committee determined on January 13, 2021 that the number of TSR units earned was 146.67% of the target, based on the percentile ranking of the Issuer's total stockholder return among the total stockholder returns for the stocks comprising a group of pre-selected peer companies over the three-year performance period. Upon this determination, the TSR units vested and were settled immediately. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.